Key result
Inflammation-dominant phenotype linked to ~62% higher risk of incident cardiometabolic multimorbidity.
Why the study?
Remnant cholesterol and C-reactive protein are emerging cardiovascular risk factors, but their joint impact on cardiometabolic multimorbidity remained unexplored.
Does a higher combined metabolic-inflammatory burden (remnant cholesterol and C-reactive protein phenotypes) increase the risk of incident cardiometabolic multimorbidity in adults free of CMM at baseline?
Cohort (n=6,883)
Does a higher combined metabolic-inflammatory burden (remnant cholesterol and C-reactive protein phenotypes) increase the risk of incident cardiometabolic multimorbidity in adults free of CMM at baseline?
A higher combined metabolic-inflammatory burden, particularly an inflammation-dominant profile characterized by elevated C-reactive protein, is significantly associated with an increased 9-year risk of incident cardiometabolic multimorbidity.
Answers are grounded in this paper and cite their sources.
Inflammation may predominate over remnant cholesterol in cardiometabolic multimorbidity risk; extends prior evidence but leaves causal and interventional implications open.
Background Remnant cholesterol (RC) and C-reactive protein (CRP) are emerging risk factors for cardiovascular diseases, but their joint impact on cardiometabolic multimorbidity (CMM) remains unexplored. This study examined their associations with the risk ofincident CMM. Methods We analyzed 6,883 participants from the China Health and Retirement Longitudinal Study (CHARLS) who were free of CMM at baseline and followed for 9 years. K-means clustering based on log-transformed RC and CRP levels was used to identify metabolic-inflammatory phenotypes. A combined risk score was calculated as the sum of the standardized values of log-transformed RC and CRP. Cox proportional hazards models and restricted cubic splines (RCS) were used to evaluate the association with incident CMM. Subgroup and sensitivity analyses were conducted to assess the consistency and robustness. Results Three phenotypes were identified: low-risk, metabolic-dominant with elevated RC, and inflammation-dominant with elevated CRP. During follow-up, 247 participants developed CMM. In the fully adjusted model, the inflammation-dominant group was associated with a significantly higher risk of incident CMM (HR: 1.62, 95% CI: 1.14-2.31, P=0.008) than the low risk group, while the metabolic-dominant group showed a non-significant risk elevation (HR: 1.03, 95% CI: 0.71-1.5, P=0.88). The combined risk score was positively associated with incident CMM, with no evidence of non-linearity. Findings were generally consistent across subgroups. Conclusions A higher combined metabolic-inflammatory burden, reflected by RC and CRP, was associated with an increased risk of incident CMM, with a stronger association observed for inflammation-dominant profiles.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) conducted a cohort in Cardiometabolic multimorbidity (n=6,883). Inflammation-dominant phenotype (elevated CRP) and metabolic-dominant phenotype (elevated remnant cholesterol) vs. Low-risk phenotype (low remnant cholesterol and CRP) was evaluated on Incident cardiometabolic multimorbidity (CMM) (HR 1.62, 95% CI 1.14-2.31, p=0.008). An inflammation-dominant phenotype with elevated CRP was associated with a higher risk of incident cardiometabolic multimorbidity vs low risk.
Synapse has enriched 10 related papers. Consider them for comparative context: